Kiniksa Announces Issuance of U.S. Patent for Treatment of Recurrent Pericarditis
HAMILTON, Bermuda, June 08, 2021 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company with a portfolio…
Pharmaceuticals, Biotechnology and Life Sciences
HAMILTON, Bermuda, June 08, 2021 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company with a portfolio…
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES MONTREAL, June 08, 2021 (GLOBE NEWSWIRE) —…
TORONTO, June 08, 2021 (GLOBE NEWSWIRE) — Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services focused…
SHANNON, Ireland, June 08, 2021 (GLOBE NEWSWIRE) — PBC Biomed, an Irish-based Medical Device Company, have entered a partnership agreement…
TORONTO, June 08, 2021 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF, Frankfurt: 31R),…
Webinar Scheduled for Wednesday, June 16th @ 12 pm EDTNEWTON, Mass., June 08, 2021 (GLOBE NEWSWIRE) — Allena Pharmaceuticals (NASDAQ:…
BION-1301 has been well-tolerated to date in patients with IgAN, with no serious adverse events (SAEs) or treatment discontinuations due…
Global results show 90% of patients are in favor of a saliva-based glucose testNEW YORK, June 08, 2021 (GLOBE NEWSWIRE)…
Topline readout of data from NORSE TWO targeted for calendar Q3 2021New Biologics License Application (BLA) filing anticipated in calendar…
SEATTLE, June 08, 2021 (GLOBE NEWSWIRE) — SEngine Precision Medicine, a precision oncology company that pre-tests drugs on patient-derived tumor…